Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model (Q35912726)

11 August 2017

Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model (English)

1 reference

11 August 2017

0 references

1 reference

L Garcia-Contreras

1

1 reference

11 August 2017

J Fiegel

2

1 reference

11 August 2017

M J Telko

3

1 reference

11 August 2017

K Elbert

4

1 reference

11 August 2017

A Hawi

5

1 reference

11 August 2017

M Thomas

6

1 reference

11 August 2017

J VerBerkmoes

7

1 reference

11 August 2017

W A Germishuizen

8

1 reference

11 August 2017

P B Fourie

9

1 reference

11 August 2017

A J Hickey

10

1 reference

11 August 2017

D Edwards

11

1 reference

11 August 2017

language of work or name

English

0 references

publication date

21 May 2007

1 reference

11 August 2017

7

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

11 August 2017

51

1 reference

11 August 2017

8

1 reference

11 August 2017

2830-2836

1 reference

Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Treatment and prevention of multidrug-resistant tuberculosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Eleven years of community-based directly observed therapy for tuberculosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

The auditory, vestibular and renal effects of capreomycin in humans

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Capreomycin in the treatment of pulmonary tuberculosis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

UV spectroscopy and reverse-phase HPLC as novel methods to determine Capreomycin of liposomal formulations

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Direct lung delivery of para-aminosalicylic acid by aerosol particles

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

The impurities of capreomycin make a difference in the safety and pharmacokinetic profiles

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Airways delivery of rifampicin microparticles for the treatment of tuberculosis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Multiple drugs in retreatment of chronic pulmonary tuberculosis. Results with capreomycin and ethambutol

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932523

Absorption, excretion and metabolism of capreomycin in normal and diseased states

24 September 2018

1 reference

12 December 2020

Capreomycin kinetics in renal impairment and clearance by hemodialysis

1 reference

12 December 2020

Large porous particles for pulmonary drug delivery

1 reference

12 December 2020

Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs

1 reference

12 December 2020

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization

1 reference

12 December 2020

Capreomycin in the re-treatment of patients with pulmonary tuberculosis

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.01164-06

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

17517845

1 reference